[go: up one dir, main page]

MX2016005645A - Composicion farmaceutica topica de acitretina. - Google Patents

Composicion farmaceutica topica de acitretina.

Info

Publication number
MX2016005645A
MX2016005645A MX2016005645A MX2016005645A MX2016005645A MX 2016005645 A MX2016005645 A MX 2016005645A MX 2016005645 A MX2016005645 A MX 2016005645A MX 2016005645 A MX2016005645 A MX 2016005645A MX 2016005645 A MX2016005645 A MX 2016005645A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
acitretin
topical pharmaceutical
relates
topical
Prior art date
Application number
MX2016005645A
Other languages
English (en)
Inventor
Jain Vikas
Dubey Vaibhav
Madan Sumit
Kumar Arora Vinod
Rao Rajesh
VENKATATESHWARAN Rathinasabapathy
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of MX2016005645A publication Critical patent/MX2016005645A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica tópica que comprende acitretina y un proceso para su preparación. También se refiere a un método para tratar trastornos de piel administrando dicha composición farmacéutica tópica.
MX2016005645A 2013-10-31 2014-10-30 Composicion farmaceutica topica de acitretina. MX2016005645A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3231DE2013 2013-10-31
PCT/IB2014/065721 WO2015063723A1 (en) 2013-10-31 2014-10-30 Topical pharmaceutical composition of acitretin

Publications (1)

Publication Number Publication Date
MX2016005645A true MX2016005645A (es) 2017-01-05

Family

ID=51947409

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005645A MX2016005645A (es) 2013-10-31 2014-10-30 Composicion farmaceutica topica de acitretina.

Country Status (8)

Country Link
US (2) US10123987B2 (es)
EP (1) EP3065702B1 (es)
AU (2) AU2014343239B2 (es)
CA (1) CA2929292C (es)
MX (1) MX2016005645A (es)
RU (1) RU2016117298A (es)
WO (1) WO2015063723A1 (es)
ZA (1) ZA201603604B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3053507A1 (en) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Compositions for treating acne
WO2018148795A1 (en) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Compositions for treating acne
AU2020315758B2 (en) 2019-07-16 2024-08-01 Donaghys Limited Transdermal solvent system and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014833A1 (en) 1989-06-07 1990-12-13 Bazzano Gail S Slow release vehicles for minimizing skin irritancy of topical compositions
AU670777B2 (en) 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
ZA954599B (en) 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
US6353029B1 (en) 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
RU2329037C2 (ru) 2003-02-14 2008-07-20 Комбинаторкс, Инкорпорейтед Комбинированная терапия для лечения иммуновоспалительных заболеваний
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20130184243A1 (en) * 2011-07-11 2013-07-18 Ceptaris Therapeutics, Inc. Compositions of alkylating agents and methods of treating skin disorders therewith
SG11201400977QA (en) * 2011-10-05 2014-04-28 Douglas Pharmaceuticals Ltd Pharmaceutical methods and topical compositions containing acitretin
CN102600177B (zh) * 2012-03-01 2014-06-11 济南龙华医药技术有限公司 一种含丙酸倍氯米松、阿达帕林和阿维a的治疗皮肤病的外用药物及其应用

Also Published As

Publication number Publication date
AU2018204223A1 (en) 2018-07-05
US20180369182A1 (en) 2018-12-27
RU2016117298A (ru) 2017-12-06
CA2929292A1 (en) 2015-05-07
US10123987B2 (en) 2018-11-13
US10342774B2 (en) 2019-07-09
AU2014343239B2 (en) 2018-03-22
EP3065702B1 (en) 2023-06-07
EP3065702A1 (en) 2016-09-14
AU2014343239A1 (en) 2016-05-19
AU2018204223B2 (en) 2020-04-02
ZA201603604B (en) 2017-05-31
WO2015063723A1 (en) 2015-05-07
CA2929292C (en) 2021-11-02
US20160271092A1 (en) 2016-09-22
WO2015063723A9 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
IL277470A (en) Manufacturing method for pharmaceutical preparations for the treatment of diseases caused by CFTR
HUE059041T2 (hu) Eljárás KIT-tel összefüggõ rendellenességek kezelésére alkalmas kompozíciók elõállítására
PH12016500094A1 (en) Autotaxin inhibitors
PH12015502075B1 (en) Treatment of cataplexy
EP3024497A4 (en) Methods and compositions for treating brain diseases
IL239851B (en) Methods and compositions for treating diseases that act to remove myelin
EA201791110A1 (ru) Сублингвальное введение рилузола
EA201790958A1 (ru) Сублингвальный препарат рилузола
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
IN2013MU03641A (es)
PH12016500525A1 (en) Substituted phenylalanine derivatives
MX2016003951A (es) Composicion para rocio topica de halobetasol.
PH12016500903A1 (en) Novel methods for treating neurodegenerative diseases
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
PH12014502065A1 (en) Vesicular formulations
IN2013MU01111A (es)
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
MX2016005645A (es) Composicion farmaceutica topica de acitretina.
IN2013MU03118A (es)
HK1211239A1 (en) Treatment regimens
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
EP3068495A4 (en) Retinoid double conjugate compounds, compositions thereof, and methods for treating of skin conditions
IN2013CH04330A (es)
IN2013MU02279A (es)

Legal Events

Date Code Title Description
HH Correction or change in general